These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19237014)

  • 1. Simvastatin inhibits sPLA2 IIa expression in aorta and myocardium.
    Wei-hua L; Chang-qing S; Qiang X; Rong W; Kai-min L
    Arch Med Res; 2009 Feb; 40(2):67-72. PubMed ID: 19237014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
    Li Z; Yang YJ; Qin XW; Ruan YM; Chen X; Meng L; Zhang HD
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3146-50. PubMed ID: 17313769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
    Hurt-Camejo E; Gautier T; Rosengren B; Dikkers A; Behrendt M; Grass DS; Rader DJ; Tietge UJ
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2707-14. PubMed ID: 24115030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of dachaihutang on expression of carnitine patmitoryl transferase-1 in vascular smooth muscle layer of atherosclerotic rabbits].
    Xuan L; Li X; Sheng X; Xu M; Che X
    Zhongguo Zhong Yao Za Zhi; 2009 Sep; 34(17):2232-5. PubMed ID: 19943493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varespladib (A-002), a secretory phospholipase A2 inhibitor, reduces atherosclerosis and aneurysm formation in ApoE-/- mice.
    Fraser H; Hislop C; Christie RM; Rick HL; Reidy CA; Chouinard ML; Eacho PI; Gould KE; Trias J
    J Cardiovasc Pharmacol; 2009 Jan; 53(1):60-5. PubMed ID: 19129734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus downregulates expression of connexin43 in rat aortic medial smooth muscle cells and can be reversed by simvastatin and losartan therapy.
    Sheu JJ; Tsai TH; Chang LT; Chiang CH; Youssef AA; Sun CK; Chang NK; Yip HK
    Chang Gung Med J; 2008; 31(2):136-44. PubMed ID: 18567413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-atherogenic effects of centipede acidic protein in rats fed an atherogenic diet.
    Wu Y; Li J; Wang J; Si Q; Zhang J; Jiang Y; Chu L
    J Ethnopharmacol; 2009 Apr; 122(3):509-16. PubMed ID: 19429321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation.
    Luchtefeld M; Bandlow N; Tietge UJ; Grote K; Pfeilschifter J; Kaszkin M; Beck S; Drexler H; Schieffer B
    Atherosclerosis; 2007 Sep; 194(1):62-70. PubMed ID: 17069818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression and activity of group IIA and X secretory phospholipase A2 in peritumoral versus central colon carcinoma tissue.
    Tribler L; Jensen LT; Jørgensen K; Brünner N; Gelb MH; Nielsen HJ; Jensen SS
    Anticancer Res; 2007; 27(5A):3179-85. PubMed ID: 17970059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changes in the endothelial expression of cell adhesion molecules and iNOS in the vessel wall after the short-term administration of simvastatin in rabbit model of atherosclerosis.
    Nachtigal P; Kopecky M; Solichova D; Zdansky P; Semecky V
    J Pharm Pharmacol; 2005 Feb; 57(2):197-203. PubMed ID: 15720783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crucial role of group IIA phospholipase A2 in pancreatitis-associated adrenal injury in acute necrotizing pancreatitis.
    Xu S; Chen C; Wang WX; Huang SR; Yu J; Chen XY
    Pathol Res Pract; 2010 Feb; 206(2):73-82. PubMed ID: 19362431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretory phospholipase A2 group V: lesion distribution, activation by arterial proteoglycans, and induction in aorta by a Western diet.
    Rosengren B; Peilot H; Umaerus M; Jönsson-Rylander AC; Mattsson-Hultén L; Hallberg C; Cronet P; Rodriguez-Lee M; Hurt-Camejo E
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1579-85. PubMed ID: 16601231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of efficacy of tibolone and simvastatin on atherosclerosis in ovariectomized cholesterol-fed rabbits.
    Cui Y; Zhao D; Liu H; Ning Z; Yang J; Qing X; Yu S; Wu C
    Maturitas; 2005 Apr; 50(4):337-43. PubMed ID: 15780535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin reduces expression and activity of lipoprotein-associated phospholipase A(2) in the aorta of hypercholesterolaemic atherosclerotic rabbits.
    Qiao Z; Ren J; Chen H
    J Int Med Res; 2009; 37(4):1029-37. PubMed ID: 19761685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of co-administration of simvastatin and alcohol in rats.
    Kolovou GD; Mikhailidis DP; Daskalova DC; Kafaltis N; Adamopoulou EN; Malakos J; Bilianou HG; Theocharis SE; Pilatis ND; Mykoniatis MG; Cokkinos DV
    In Vivo; 2003; 17(6):523-7. PubMed ID: 14758716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. sPLA2-IIA Augments Oxidized LDL-Induced MCP-1 Expression in Vitro Through Activation of Akt.
    Guo Y; Li B; Xu X; Wu R; Li W
    Cell Physiol Biochem; 2015; 37(4):1345-54. PubMed ID: 26488172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine and paracrine transcriptional regulation of type IIA secretory phospholipase A2 gene in vascular smooth muscle cells.
    Jaulmes A; Janvier B; Andreani M; Raymondjean M
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1161-7. PubMed ID: 15802623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vav3 oncogene is involved in regulation of secretory phospholipase A2-IIa expression in prostate cancer.
    Dong Z; Liu Y; Levin L; Oleksowicz L; Wang J; Lu S
    Oncol Rep; 2011 Jun; 25(6):1511-6. PubMed ID: 21455584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice.
    Guo H; Shi Y; Liu L; Sun A; Xu F; Chi J
    Arch Med Res; 2009 Jul; 40(5):345-51. PubMed ID: 19766896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of interleukin-1beta-induced group IIA secretory phospholipase A2 expression by peroxisome proliferator-activated receptors (PPARs) in rat vascular smooth muscle cells: cooperation between PPARbeta and the proto-oncogene BCL-6.
    Ravaux L; Denoyelle C; Monne C; Limon I; Raymondjean M; El Hadri K
    Mol Cell Biol; 2007 Dec; 27(23):8374-87. PubMed ID: 17908795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.